Wattanapat Hospital Trang Public Company Limited Stocks

THB 5.85Last Updated 26.01.2026

Issuer Rating

5/7

Performance

Strong

Risk

Considerable

Recommendation

Hold

Market Cap

THB 130.76M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
THB 5.85
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Wattanapat Hospital Trang Public Company Limited operates hospitals and clinics in Thailand. The company operates medical clinics, including obstetrics and gynecology, surgery, internal medicine, pediatric, neurology, cardiology, eye, ENT, skin and beauty, dental, and wellness center, as well as X-Ray and MRI center, WPH emergency center, emergency center, kidney clinic and hemodialysis center, physical therapy...

Company Valuation

Undervalued
6/7

From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, of fair value on EV/E

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Very favourable
7/7

The average target price of WPH.BK is 11 and suggests 88% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks